Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chen-Ze Zhao"'
Publikováno v:
World Journal of Clinical Cases. 10:8255-8261
Publikováno v:
Cell Biology International. 41:982-990
Farnesyl pyrophosphate synthase (FPPS) is a key enzyme in the mevalonate pathway. Our previous studies have indicated that cardiac-specific overexpression of FPPS induces cardiac hypertrophy and dysfunction in mice, and inhibition of FPPS prevents an
Publikováno v:
The International Journal of Biochemistry & Cell Biology. 45:657-666
Farnesyl pyrophosphate synthase (FPPS), as a key branchpoint of the mevalonate pathway, catalyzes the synthesis of isoprenoid intermediates. The isoprenoid intermediates are needed for protein isoprenylation to participate in cardiac remodeling. We h
Autor:
Jie Ding, Chen-Ze Zhao, Yun Mou, Dongpu Dai, Jian Yang, Xu-Ming Zhao, Huan-Dong Wu, Shen-Jiang Hu, Bin Chen
Publikováno v:
Scientific Reports
Farnesyl pyrophosphate synthase (FPPS) is a key enzyme in the mevalonate pathway. In our previous studies, we find that inhibition of FPPS attenuates angiotensin II-induced cardiac hypertrophy and fibrosis by suppressing RhoA while FPPS and Ras are u
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2015 (2015)
BioMed Research International, Vol 2015 (2015)
Farnesyl pyrophosphate synthase (FPPS) plays a vital role in the mevalonate pathway and has been shown to be involved in hypertrophy and cardiovascular diseases. Lentivirus-mediated RNA interference (RNAi) to knock down a gene of interest has become
Autor:
Yang Ye, Jian Yang, Chen-Ze Zhao, Yun Mou, Liang Zhou, Chang-Qing Du, Huan-Huan Zhu, Tao Wu, Jun-Chang Jiang, Shen-Jiang Hu
Publikováno v:
Cardiovascular research. 97(3)
Aims Farnesyl pyrophosphate synthase (FPPS) is a key enzyme in the mevalonate pathway. In our previous study, we found that inhibition of FPPS attenuates cardiac hypertrophy in spontaneously hypertensive rats (SHRs) and prevents angiotensin (Ang) II-